Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$144.38 - $157.78 $664,148 - $725,788
4,600 New
4,600 $672,000
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $4.38 Million - $4.78 Million
30,100 Added 304.04%
40,000 $6.27 Million
Q3 2023

Nov 03, 2023

SELL
$155.75 - $174.48 $6.25 Million - $7 Million
-40,100 Reduced 80.2%
9,900 $1.54 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $40.8 Million - $44 Million
-264,600 Reduced 84.11%
50,000 $8.28 Million
Q1 2023

May 10, 2023

BUY
$151.05 - $180.26 $23.7 Million - $28.3 Million
156,800 Added 99.37%
314,600 $48.8 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $85.5 Million - $95.9 Million
-533,600 Reduced 77.18%
157,800 $27.9 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $4.1 Million - $4.56 Million
25,400 Added 3.81%
691,400 $113 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $44 Million - $48.7 Million
261,600 Added 64.69%
666,000 $118 Million
Q1 2022

May 17, 2022

BUY
$158.14 - $179.59 $64 Million - $72.6 Million
404,400 New
404,400 $71.7 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $7.05 Million - $7.82 Million
-45,200 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $11.3 Million - $12.5 Million
-69,800 Reduced 60.7%
45,200 $7.3 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $18.3 Million - $19.7 Million
114,900 Added 114900.0%
115,000 $18.9 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $15,307 - $17,048
100 New
100 $16,000
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $5.36 Million - $6.47 Million
-41,600 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $377,876 - $523,566
-3,400 Reduced 7.56%
41,600 $5.46 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $5.74 Million - $6.59 Million
45,000 New
45,000 $6.56 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.